Successful treatment of dermatomyositis during pregnancy with intravenous immunoglobulin monotherapy

Obstetrics and Gynecology

Volumn 109, Issue 2 PART 2 SUPPL., 2007, Pages 561-563

  Williams, Lloyd ^b   Chang, Peter Y ^b   Park, Ellen ^b   Gorson, Kenneth C ^b   Bayer Zwirello, Lucy ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; IMMUNOGLOBULIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; FEMALE; HUMAN; PREGNANCY; PRIMIGRAVIDA; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; CREATINE KINASE; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS;

EID: 33846418742     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000253244.45837.7c     Document Type: Article

References (8)

1. Dalakas MC. The role of high-dose immune globulin intravenous in the treatment of dermatomyositis. Int Immunopharmacol 2006;6:550-6.
2. Silva CA, Sultan SM, Isenberg DA. Pregnancy outcome in adult-onset idiopathic inflammatory myopathy. Rheumatology (Oxford) 2003;42:1168-72.
3. Dalakas MC. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines. Muscle Nerve 1999;22:1479-97.
4. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329:1993-2000.
5. Mosca M, Strigini F, Carmignani A, D'ascanio A, Genazzani AR, Bombardieri S. Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy. Arthritis Rheum 2005;53:119-21.
6. Clark AL. Clinical uses of intravenous immunoglobulin in pregnancy. Clin Obstet Gynecol 1999;42:368-80.
7. Artlett CM, Ramos R, Jiminez SA, Patterson K, Miller FW, Rider LG. Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group. Lancet 2000;356:2155-6.
8. Sereda D, Werth VP. Improvement in dermatomyositis rash associated with the use of antiestrogen medication. Arch Dermatol 2006;142:70-2.